Redpoint Bio Corp. (RPBC.OB) Receives Patent Covering Screening Technology that may Offset Diabetes
Located in Ewing, New Jersey, Redpoint Bio is in the development of creating healthier and more tasteful foods that can contribute to the overall health of the world’s population. Today, Redpoint Bio announced they have received a new patent covering screening technology. The patent is entitled “High Throughput Screening Assay for the TRPm5 Ion Channel.” Issued under Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office, the patent will cover methods of using high-throughput screen to discover certain modulators of the TRPm5 ion channel. The TRPm5 ion channel was originally identified as an important component of taste signaling…